BridgeMD
New treatment option for Lung Cancer (Diagnosis)
Official title Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection
ClinicalTrials.gov ID: NCT07552584
What this study is testing
- What it's testing
- The study is a prospective, non-randomized feasibility study evaluating blood sample and machine learning-based risk stratification for lung cancer in patients with COPD (chronic obstructive pulmonary disease). Patients with COPD will be recruited in general practice, where they will have a blood sample drawn.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- Diagnosed with COPD.
- =\> 50 years.
- Former or current smoker.
- Speaks and understands Danish.
- Able to give informed consent to participation.
You likely can't join if
- Had a CT scan of the thorax within 6 months.
- Received active treatment for cancer within one year (except non-melanoma skin cancer and carcinoma in situ cervicis uteri).
- Diagnosed with cancer within one year (except non-melanoma skin cancer and carcinoma in situ cervicis uteri).
- Presents with symptoms giving suspicion of cancer (except non-melanoma skin cancer and carcinoma in situ cervicis uteri).
- In a condition not allowing diagnostic workup for or treatment of lung cancer.
- Does not have Eboks (electronic communication with Danish authorities).
The study team makes the final eligibility decision.
Where it's taking place
- Vejle, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vejle, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.